风湿病与自身免疫(英文)(Rheumatology & Autoimmunity) 知网目次万方目次维普目次
- 国级普刊
- 主管单位:
中国科学技术协会
- 主办单位:
中华医学会
- 国际刊号:
2767-1410;EISSN 2767-1429
- 国内刊号:
10-1881/R
- 学科分类:
- 字数:
4000-26000
- 有无基金:
/有基金 100.0%
- 周期:
CN外文-季刊
- 特殊属性:
外文期刊
- 电话:
010-51322174;010-51322118(官网电话)
- 邮箱:
rai@cmaph.org(官网邮箱)
- 复合因子:
0
- 综合因子:
0
- 收录:
知网目次,万方目次,维普目次
- 级别:
国级普刊
期刊简介
《风湿病与自身免疫(英文)(Rheumatology & Autoimmunity)》期刊已被查看: 次
更新频次
高频栏目:
REVIEWS-100%-期平均发文量2篇
ORIGINAL ARTICLES-100%-期平均发文量2篇
CASE REPORT-100%-期平均发文量1篇
LETTERS TO THE EDITOR-100%-期平均发文量2篇
RESEARCH HIGHLIGHTS-100%-期平均发文量1篇
中频栏目:
CLINICAL IMAGE-50.0%-期平均发文量1篇
单位占比
其他-100.0%一作占比
/有基金-100.0%投稿指南
1、投稿方式:在线投稿。
2、刊内网址:(202301期)
http://www.rheumatology-autoimmunity.org/
https://onlinelibrary.wiley.com/journal/27671429
https://mc.manuscriptcentral.com/rai(投稿系统)
3、期刊主页:
https://www.yiigle.com/Journal/Detail/200
4、官网邮箱:rai@cmaph.org
5、官网电话:010-51322174;010-51322118
6、出刊日期:季刊,逢季末月出版。
2024年4月17日星期三
Rheumatology & Autoimmunity 创刊
【微信公众号“WileyOALandscape”信息】
Rheumatology & Autoimmunity是由中华医学会主办、中华医学杂志社与Wiley合作出版发行的全英文风湿病与免疫学专业期刊,采取开放(Open-access)获取模式,所有发表文章均可免费阅读,文章一经发表,可以第一时间被全球读者检索、阅读和下载。本刊发表风湿病与免疫学领域中临床诊治、转化及基础研究方面的新进展。涵盖风湿病学和免疫学的各个领域,旨在为国内外相关领域科学家与临床专家提供一个学术交流、信息传递的平台,同时提升我国风湿病与免疫学在国际学术界的影响力和竞争力。
Rheumatology & Autoimmunity主编由北京大学人民医院栗占国教授担任,副总编、顾问及编委由全球10多个国家的著名科学家构成。2021年,本刊入选中国科技期刊卓越行动计划高起点期刊。
本期刊发表论文类型包括Original articles(原创论著,基础与临床), Editorials(社论), Highlight(热点),Consensuses and Guidelines(共识与指南), Reviews(综述), Perspectives(观点), Letters(简讯), Commentaries(评论), Case reports(案例)等,对于原创性成果采取“快速通道”模式,帮助作者以最快的速度发表文章。
2021年至2023年,Rheumatology & Autoimmunity目前免收论文出版费。
期刊发表范围
涵盖风湿病学和临床免疫学的各个领域,包括各种风湿病、自身免疫病以及免疫学基础及转化医学研究。
感兴趣的主题
各种风湿病和自身免疫病的基础和临床研究,包括但不限于以下疾病:
• Rheumatoid Arthritis
类风湿关节炎
• Systemic Lupus Erythematosus
系统性红斑狼疮
• Sjogren Syndrome
干燥综合征
• Spondyloarthritis
脊柱关节炎
• Gout
痛风
• Osteoarthritis
骨关节炎
• Psoriatic Arthritis
银屑病关节炎
• Inflammatory Myopathy
炎性肌病
• Systematic Sclerosis
系统性硬化症
• Systemic Vasculitis
系统性血管炎
Rheumatology & Autoimmunity竭诚欢迎风湿病与免疫学领域的科研工作者、医生、研究生积极向期刊投稿。
期刊主页:
https://onlinelibrary.wiley.com/journal/27671429
主编简介
栗占国教授
北京大学人民医院临床免疫中心,中华医学会风湿病学分会前任主任委员,国际风湿病联盟(ILAR)前主席和亚太风湿病联盟(APLAR) 前主席,中国免疫学会临床免疫分会主任委员
Rheumatology & Autoimmunity竭诚欢迎风湿病与免疫学领域的科研工作者、医生、研究生积极向期刊投稿。
投稿链接:
https://mc.manuscriptcentral.com/rai
Rheumatology & Autoimmunity 投稿指南
【官网信息】
Author Guidelines
1. SUBMISSION
Thank you for your interest in Rheumatology & Autoimmunity. Note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium.
Free Format submission
Rheumatology & Autoimmunity now offers Free Format submission for a simplified and streamlined submission process.
Cover letter
A cover letter should be included in the ‘Cover Letter Field’ of the ScholarOne system. The text can be entered directly into the field or uploaded as a file.
The cover letter must contain:
i) A statement confirming the paper has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium;
ii) An acknowledgment that all authors have contributed significantly and in keeping with the latest guidelines of the International Committee of Medical Journal Editors, each author’s contribution to the paper is to be described, i.e., what role each author participated in;
iii) a statement confirming that all authors are in agreement with the content of the manuscript.
Submission
Once you have prepared your submission in accordance with the Guidelines, manuscripts should be submitted online at http://mc.manuscriptcentral.com/rai
We look forward to your submission.
2. AIMS AND SCOPE
Rheumatology & Autoimmunity, hosted by Chinese Medical Association, is a peer-reviewed, open access journal focusing on cutting-edge research in rheumatology and autoimmune diseases. Rheumatology & Autoimmunity’s scope is broad, covering the basic, clinical, and translational medical advancements across the full spectrum of rheumatology and autoimmunity. This journal publishes a variety of article types including Original Article, Review, Editorial, Research Highlights, Consensus, Letter, Commentary, Case Report, Meeting Report, Technical Note, Clinical Image, Brief Report and Study Protocols.
3. MANUSCRIPT CATEGORIES AND REQUIREMENTS
(1) Original Article
Word limit: 4000 words maximum including abstract but excluding references, tables and figures. Abstract: 250 words maximum, with sub-headers. References: no limit. Figures/tables: no limit, but 8 figures should be sufficient.
Description: Full-length reports of current research in either basic or clinical science.
(2) Editorial
Word Limit: 1500 words maximum. Abstract: not required. References: 5 maximum.
Description: Proposals for Editorials may be submitted; however, in this case authors should only send an outline of the proposed paper for initial consideration.
(3) Research Highlights
Word Limit: 1000 words maximum. Abstract: not required. References: 20 maximum.
Description: Recent Research highlights published in Rheumatology & Autoimmunity. Personal opinion on a topic, often with a novel/imaginative approach to a provocative question, with an engaging though rigorous investigation, including new developments, and moderate referencing.
(4) Consensus
Word limit: 5000 words maximum including abstract but excluding references, tables and figures. Abstract: 250 words maximum, unstructured (no use of sub-headers). References: no limit. Figures/tables: minimum 1 image or figure.
Description: Consensus needs to be the product of a large group of individuals who are recognized authorities in their field. Consensus will be written by a working party to include a steering committee (usually at least 4 members) and other authors representing a wide range of those with special relevant expertise as well as those whose everyday practice will be influenced by the guidelines.
(5) Review
Word limit: 5000 words maximum including abstract but excluding references, tables and figures. Abstract: 250 words maximum, unstructured (no use of sub-headers). References: no limit. Figures/tables: maximum 6 images or figures.
Description: Review should not simply summarize information, but also discuss the importance and impact of the data providing a clear view on how these insights have transformed or will transform the field. Authors of review articles are encouraged to include several figures and tables to summarize and visualize data.
……
更多详情:
https://onlinelibrary.wiley.com/page/journal/27671429/homepage/author-guidelines
中国全科医学发文选摘
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
《风湿病与自身免疫(英文)(Rheumatology & Autoimmunity)》同类内科学期刊
-
中华胃肠外科杂志(原:中国胃肠外科杂志)
北核,CSCD,科核,武A,高T2
CN中文-月刊影响因子1.903
-
肠外与肠内营养
北核,CSCD,科核,武A+,高T3
CN中文-双月刊影响因子1.694
-
中华心血管病杂志
北核,CSCD,科核,武A+,高T1
CN中文-月刊影响因子2.576
-
中国糖尿病杂志
北核,CSCD,科核,武A
CN中文-月刊影响因子1.554
-
中国老年学杂志
北核,武A+
CN中文-半月刊影响因子1.791
-
中国实用内科杂志
北核,CSCD,科核,武A
CN中文-月刊影响因子1.51
-
中国呼吸与危重监护杂志
CSCD,科核,武A-,高T3
CN中文-月刊影响因子1.753
-
中华风湿病学杂志
科核,CSCD扩,武B+
CN中文-月刊影响因子0.744
常见问题
-
哪些期刊可以用来评职称?
1、期刊要具备正规性和合法性,需在国家新闻出版总署备案,具备国内刊号(cn)。2、期刊要具备学术性,例如该期刊需被国内主流学术、数据库收录,例如被知网,万方,维普收录。具体详情可以咨询我们的客服老师为您解答。
-
你们的服务可以保证文章被发表吗?
期刊发表的成功与否,主要取决于文章内容的质量。期刊编辑会根据研究领域、创新性等多因素进行考量。我们会帮助您理解期刊的发表要求,助力提升发表几率,从而增加发表的机会。
-
请问发表一篇期刊的费用是多少?
期刊的种类繁多,其费用也各不相同。根据您的需求,将为您推荐最具性价比的期刊,让您能更便捷地找到心仪的期刊。一般来说,只要符合职称评定要求的,大多数作者都会选择性价比最高的期刊作为首选目标。
-
如果发表不成功可以退款吗?
如果因为我方原因导致未能发表成功,我们将全额退还相关费用。需要明确的是,稿件能否发表主要取决于期刊的独立考量。为了提升您的发表几率,我们会提供专业的指导和支持,帮助您避免拒稿,并助力提高您的稿件质量。
-
请问文章发表需要多长时间?
不同级别的期刊发表时间是不一样的。无论是普刊还是核心期刊,建议您提前准备。普刊需提前3-6个月,而核心期刊需提前一年左右。为确保职称评定流程顺利进行,建议您提前半年到一年进行准备,以免错过申请的最佳时机。
-
期刊发表能加急见刊吗?
为了确保顺利发表,建议您提前一些时间进行安排。本站仅提供投稿发表咨询服务,需要用户自己向出版商投稿且没有绿色通道,是否录用一切以出版商通知为准。